Horan Securities’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Horan Securities's HALO Position: Q3 2023 in Review
Horan Securities sold out of Halozyme (HALO) in Q3 2023, closing a stake of 266 shares — an estimated $9.6K sold.
Horan Securities first reported a position in HALO in Q3 2016 and held it in 25 quarters. The position peaked at $15.1K in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.
- Horan Securities reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
- Horan Securities sold 266 Halozyme shares in Q3 2023, an estimated $9.6K.
- Horan Securities first reported a position in Halozyme in Q3 2016 and held it in 25 quarters.
- Horan Securities's Halozyme position peaked at $15.1K in Q4 2022.
- 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.
Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.